171
Participants
Start Date
September 3, 2021
Primary Completion Date
December 4, 2024
Study Completion Date
December 31, 2025
Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device
Patients suffering from a distal intracranial aneurysm will be treated endovascularly with the p64 MW HPC Flow Modulation Device.
Universitätsspital Basel, Basel
Fondazione I.R.C.C.S. Instituto Neurologico Carlo Besta, Milan
CHU Bordeaux, Bordeaux
CHU de Montpellier, Montpellier
CHU Reims - Hôpital Maison Blanche, Reims
CHU de Lyon, Lyon
Klinikum Stuttgart, Stuttgart
Klinikum der LMU München, München
Universitätsklinikum Augsburg, Augsburg
Klinikum Nürnberg Süd, Nuremberg
Hôpital Bicêtre, Le Kremlin-Bicêtre
Helios Klinikum Erfurt, Erfurt
Hadassah University Medical Center, Jerusalem
Universitätsklinikum Halle (Saale), Halle
Klinikum Vest Recklinghausen, Recklinghausen
Western General Hospital, Edinburgh
UNLP Košice, Košice
Queen Elisabeth Hospital Birmingham, Birmingham
Lead Sponsor
Phenox GmbH
INDUSTRY